Methylphenidate-Associated Hyperekplexia
- PMID: 39792503
- DOI: 10.1097/MJT.0000000000001772
Methylphenidate-Associated Hyperekplexia
Conflict of interest statement
The authors have no conflicts of interest to declare.
References
-
- Saini AG, Pandey S. Hyperekplexia and other startle syndromes. J Neurol Sci. 2020;416:117051.
-
- Naguy A, Alamiri B. PTSD- Inevitable or preventable? Australas Psychiatry. 2018;26:670.
-
- Naguy A. Eponymous psychiatric syndromes revisited. Prim Care Companion CNS Disord. 2018;20:17br02195.
-
- Naguy A, Alamiri B, Elsori D, et al. Methylphenidate-associated onychotillomania, myoclonus, and enuresis reversed by switching to atomoxetine. Am J Ther. 2019;26:e614–e616.
-
- Naguy A, Hashem MS, AlKhadhar S. Atypical antipsychotics for Attention-Deficit/Hyperactivity disorder- science, art, or fad? Eur Psychiatry. 2019;62:58–59.
LinkOut - more resources
Full Text Sources